HCG - Healthcare Global Enterprises

Healthcare Global Enterprises

HCG · Healthcare > Hospital & Healthcare Services · Chairman: B S Ajai Kumar Listing date: March 31, 2016 · Employees: 5454 · Bangalore · http://www.hcgel.com

Stock Price vs Company Growth

3.0%

7.4%

8.8%

28.1%

59.4%

43.9%

all

16.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 742 3.0%

615

804

Company Overview

Sales

2,310 Cr

Growth: 15.2%

Profit after Tax

37.1 Cr

Growth: -16.5%

Mid Cap

10,459 Cr

P/E: 283.3x

Industry P/E: 50.4x

Fundamentals

Sales (Cr)	₹ 2,310
Growth	15.2%
EBITDA	17.5%
P/S	4.5x
Dividend	0.0%
P/E	283.3x
Book Value	₹ 65.8
PEG Ratio	18.8x
ROE	4.2%
P/B	11.5x

Shareholding Pattern

Institutions

International Finance Corporation

3.48 %

Sundaram Mutual Fund A/C Sundaram Balanced Advantage Fund

2.88 %

Wellington Trust Company, National Association Mul

1.64 %

Tata Mutual Fund - Tata Small Cap Fund

1.6 %

Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund

1.35 %

Promoters

Aceso Company Pte Ltd.

53.67 %

B S Ajaikumar

14.21 %

Asmitha Ajaikumar

0.26 %

Aagnika Ajaikumar

0.26 %

Others

Gopi Chand Mamillapalli

1.44 %

Zafar Ahmadullah

1.2 %

Il And Fs Trust Company Limited

1.16 %

Increase Decrease No change

Company Profile Detailed

The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann’ brand.Major events and milestones2005: Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited.

Belongs to (11 Indices) view more

Investors (174)

zafar.ah...

the.pabr...

tata.mut...

Followers (10)

nitin2

keerthi

deepak